We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$16.8B
AUM Growth
+$1.95B
Cap. Flow
+$1.49B
Cap. Flow %
8.85%
Top 10 Hldgs %
30.31%
Holding
2,964
New
179
Increased
2,266
Reduced
433
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$118M
2
AAPL icon
Apple
AAPL
+$96.6M
3
NVDA icon
NVIDIA
NVDA
+$91.2M
4
AMZN icon
Amazon
AMZN
+$67.2M
5
META icon
Meta Platforms (Facebook)
META
+$38.6M

Sector Composition

Rank Sector Weight
1 Technology 30.48%
2 Financials 11.78%
3 Healthcare 11.37%
4 Consumer Discretionary 10.49%
5 Industrials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPNS
1626
DELISTED
Sapiens International
SPNS
$593K ﹤0.01%
17,474
+1,787
+11% +$58.3K
WULF icon
1627
TeraWulf
WULF
$8.14B
$592K ﹤0.01%
133,126
+71,333
+115% +$192K
JACK icon
1628
Jack in the Box
JACK
$358M
$591K ﹤0.01%
11,599
+1,078
+10% +$60.5K
CNNE icon
1629
Cannae Holdings
CNNE
$675M
$590K ﹤0.01%
32,549
-1,374
-4% -$26.7K
EYE icon
1630
National Vision
EYE
$1.54B
$590K ﹤0.01%
45,082
+4,129
+10% +$67.6K
PEBO icon
1631
Peoples Bancorp
PEBO
$1.48B
$589K ﹤0.01%
19,640
+1,850
+10% +$53.7K
LGF.B
1632
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$589K ﹤0.01%
68,701
+12,056
+21% +$108K
TRNS icon
1633
Transcat
TRNS
$888M
$588K ﹤0.01%
4,911
+610
+14% +$72K
AMRX icon
1634
Amneal Pharmaceuticals
AMRX
$6.15B
$586K ﹤0.01%
92,342
+35,634
+63% +$226K
GPRE icon
1635
Green Plains
GPRE
$1.06B
$585K ﹤0.01%
36,886
+6,199
+20% +$119K
MKL icon
1636
Markel Group
MKL
$22.8B
$585K ﹤0.01%
371
+114
+44% +$177K
TARS icon
1637
Tarsus Pharmaceuticals
TARS
$3.07B
$584K ﹤0.01%
21,504
+5,964
+38% +$201K
CXM icon
1638
Sprinklr
CXM
$1.58B
$584K ﹤0.01%
60,711
+6,034
+11% +$67.4K
GABC icon
1639
German American Bancorp
GABC
$1.91B
$584K ﹤0.01%
16,509
+1,972
+14% +$64.3K
AHCO icon
1640
AdaptHealth
AHCO
$760M
$583K ﹤0.01%
58,332
+7,742
+15% +$78.7K
ACH
1641
Accendra Health
ACH
$84.6M
$583K ﹤0.01%
43,165
+4,988
+13% +$102K
HRMY icon
1642
Harmony Biosciences
HRMY
$2.32B
$582K ﹤0.01%
19,282
+1,735
+10% +$52.2K
SABR icon
1643
Sabre
SABR
$831M
$581K ﹤0.01%
217,542
+89,208
+70% +$250K
HLF icon
1644
Herbalife
HLF
$1.23B
$580K ﹤0.01%
55,787
+8,513
+18% +$85.1K
BBT
1645
Beacon Financial Corp
BBT
$2.71B
$579K ﹤0.01%
25,386
+2,470
+11% +$54.2K
QCRH icon
1646
QCR Holdings
QCRH
$1.73B
$579K ﹤0.01%
9,644
+896
+10% +$51.2K
COUR icon
1647
Coursera
COUR
$1.48B
$576K ﹤0.01%
80,401
+11,299
+16% +$107K
AORT icon
1648
Artivion
AORT
$1.39B
$575K ﹤0.01%
22,432
+2,157
+11% +$48.3K
IMKTA icon
1649
Ingles Markets
IMKTA
$1.66B
$574K ﹤0.01%
8,372
+1,310
+19% +$94.8K
ARQT icon
1650
Arcutis Biotherapeutics
ARQT
$3.3B
$573K ﹤0.01%
61,658
+17,857
+41% +$161K

Similar funds

MetLife Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, MetLife Investment Management held 2,964 positions worth $16.8B, up 13% from $14.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

MetLife Investment Management deployed $1.49B of net new capital in Q2 2024, opening 179 new positions and adding to 2,266 existing holdings. Its largest new stake was GE Vernova: 73,079 shares worth $12.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92.7M trimmed.

  • MetLife Investment Management's largest Q2 2024 buy was GE Vernova: 73,079 shares worth $12.5M.
  • MetLife Investment Management added most to Microsoft in Q2 2024, an estimated $118M increase.
  • MetLife Investment Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.7M.
  • MetLife Investment Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $14.4M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $16.8B portfolio in Q2 2024.
  • MetLife Investment Management opened 179 new positions and closed 84 in Q2 2024.
  • MetLife Investment Management's portfolio value rose 13% quarter-over-quarter to $16.8B.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.